Toyoaki Hida

13PUBLICATIONS
15CO-AUTHORS
Haematological tumoursMolecular targetsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 09, 2026
Pathophysiology and treatment of leptomeningeal metastases in lung cancer.

Toyoaki Hida

|Sep 10, 2022
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.

Makoto Nishio, Terufumi Kato, Ryo Toyozawa

|Sep 20, 2021
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.

Miyako Satouchi, Kaname Nosaki, Toshiaki Takahashi

|Jan 28, 2021
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 study.

Takashi Seto, Kadoaki Ohashi, Shunichi Sugawara

|Oct 22, 2020
Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy.

Nobuhiro Kanaji, Junichi Shimizu, Kenichiro Sakai

|Sep 14, 2020
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.

Miyako Satouchi, Kaname Nosaki, Toshiaki Takahashi

Pageof 3

Frequent Collaborators

4 joint publications

Makoto Nishio

3 joint publications

Isamu Okamoto

2 joint publications

Katsuyuki Hotta

2 joint publications

Miyako Satouchi